sr 46349b has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaouloff, F; Kulikov, A; Mormède, P | 1 |
| Cruz, AP; Morato, S; Motta, VA; Pinheiro, AP; Setem, J | 1 |
2 other study(ies) available for sr 46349b and Anxiety
| Article | Year |
|---|---|
Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.
Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Body Weight; Cerebral Cortex; Female; Fluorobenzenes; Ketanserin; Male; Maze Learning; Phenols; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Exploratory Behavior; Fluorobenzenes; Indoles; Male; Naphthalenes; Phenols; Piperazines; Pyrimidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Risk Assessment; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |